High cholesterol levels are considered a leading risk factor for heart diseases and strokes across the world. Thus, local ...
A new cholesterol breakthrough could help fight stubborn LDL. Researchers reveal how a protein switch might unlock a new ...
Morning Overview on MSN
A one-shot gene edit safely lowered cholesterol in its first human trial
A single infusion of an experimental gene-editing therapy called VERVE-102 lowered LDL cholesterol in people with dangerously high lipid levels, marking the first time in vivo base editing of the ...
Cholesterol-related heart disease remains the leading cause of death worldwide, and while doctors have more tools than ever to treat it, many patients still can’t achieve safe cholesterol levels or ...
National Institute of Health (NIH) scientists have made a significant breakthrough in understanding how "bad" cholesterol, known as low-density lipoprotein-cholesterol or LDL-C, builds up in the body.
YouTube on MSN
Cholesterol isn’t the real problem
Is cholesterol actually clogging your arteries, or has the media misrepresented this essential molecule? This video exposes ...
Enlicitide is the first oral PCSK9 inhibitor to demonstrate statistically significant and clinically meaningful reductions in LDL-C compared to placebo in Phase 3 trials RAHWAY, N.J.--(BUSINESS WIRE)- ...
Cholesterol-related heart disease remains the leading cause of death worldwide, and while doctors have more tools than ever ...
LYON, France — Lerodalcibep, a novel, third-generation anti–proprotein convertase subtilisin/kexin type 9 (PCSK9) inhibitor, helps high-risk patients already receiving maximally tolerated statins to ...
Jessica Rendall is a reporter with experience covering a variety of health and wellness topics, including chronic disease, ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results